標題: Titlebook: Cystoid Macular Edema; Medical and Surgical Shlomit Schaal,Henry J. Kaplan Book 2017 Springer International Publishing Switzerland 2017 CME [打印本頁] 作者: antibody 時間: 2025-3-21 16:37
書目名稱Cystoid Macular Edema影響因子(影響力)
書目名稱Cystoid Macular Edema影響因子(影響力)學科排名
書目名稱Cystoid Macular Edema網絡公開度
書目名稱Cystoid Macular Edema網絡公開度學科排名
書目名稱Cystoid Macular Edema被引頻次
書目名稱Cystoid Macular Edema被引頻次學科排名
書目名稱Cystoid Macular Edema年度引用
書目名稱Cystoid Macular Edema年度引用學科排名
書目名稱Cystoid Macular Edema讀者反饋
書目名稱Cystoid Macular Edema讀者反饋學科排名
作者: inscribe 時間: 2025-3-21 22:24
Medical Management of CME Associated with Retinal Vascular Occlusionst of choice. A prompt start of treatment seems to be important to attain best possible visual recovery. Most specialists agree that treatment should commence with repeated, monthly injections until visual acuity remains stable for at least 2–3 months and may then be continued as needed (“pro-re-nata作者: Inelasticity 時間: 2025-3-22 03:50 作者: 云狀 時間: 2025-3-22 06:13 作者: CORD 時間: 2025-3-22 12:02
Surgical Management of CME Associated with Vitreoretinal Interfacement of this entity is described in another chapter. The differential diagnosis should include epiretinal membrane, macular hole, age-related macular degeneration, central serous chorioretinopathy, and, most importantly, vitreomacular traction (VMT) syndrome [1–4].作者: emulsify 時間: 2025-3-22 15:34
ve surgical procedures. Additionally, since therapeutic approaches to CME depend on a clear understanding of pathophysiologic mechanisms and the structural changes in the vitreous and neurosensory retina revealed by imaging studies, these?aspects are carefully considered as well..978-3-319-81961-7978-3-319-39766-5作者: emulsify 時間: 2025-3-22 17:48
Book 2017oaches to CME depend on a clear understanding of pathophysiologic mechanisms and the structural changes in the vitreous and neurosensory retina revealed by imaging studies, these?aspects are carefully considered as well..作者: 飛來飛去真休 時間: 2025-3-22 22:49 作者: 進步 時間: 2025-3-23 03:57 作者: Cardioplegia 時間: 2025-3-23 06:15
und andere Erz?hlungen (1946) : he underlying cause of uveitis is in question, a diagnostic vitrectomy may also have the secondary effect of decreasing macular edema..Uveitic ME is often associated with additional structural complications affecting the posterior segment. Vitrectomy may be indicated for epiretinal membrane, vitreom作者: Firefly 時間: 2025-3-23 09:50 作者: 不可比擬 時間: 2025-3-23 16:09 作者: Lumbar-Spine 時間: 2025-3-23 19:19
Book 2017d macular edema (CME) and explains the current understanding of the pathophysiology of the condition and methods of diagnosis. The management approach is clearly detailed for each potential presentation, including CME occurring in association with uveitis, diabetes mellitus, vitreoretinal interface 作者: 盤旋 時間: 2025-3-24 00:51
hanisms and structural changes relevant to therapy.Meets the.Written for comprehensive ophthalmologists and vitreoretinal surgeons, this book discusses state-of-the-art medical and surgical management of cystoid macular edema (CME) and explains the current understanding of the pathophysiology of the作者: GORGE 時間: 2025-3-24 05:17 作者: EXALT 時間: 2025-3-24 08:55
Sagen und Legenden (1938–1940) : lens fragment (RLF) is a serious event in cataract surgery that occurs in about 1 % of cases. It frequently requires both medical and surgical intervention to minimize complications and visual loss. In this chapter, we will discuss the pathophysiology of CME in RLF and proper medical and surgical management.作者: 小步走路 時間: 2025-3-24 11:14 作者: 咒語 時間: 2025-3-24 16:14
Medical Management of CME Associated with Uveitisneous interferon alpha, and systemic antitumor necrosis factor agents have also demonstrated efficacy in treating inflammatory macular edema. The decision about which agent is most appropriate can be challenging and should be tailored to the clinical scenario.作者: Charitable 時間: 2025-3-24 21:42 作者: 無能性 時間: 2025-3-25 01:36 作者: 敘述 時間: 2025-3-25 05:16
Introduction termed “cystoid macular edema” (CME), which represents the collection of excess fluid in “cysts” within the neurosensory retina, it is more broadly defined as extracellular accumulation of fluid within the outer plexiform layer of the retina. Thus, CME should be referred to as a subtype of macular 作者: llibretto 時間: 2025-3-25 10:07 作者: Ruptured-Disk 時間: 2025-3-25 14:28 作者: 使堅硬 時間: 2025-3-25 17:46
Medical Management of CME Associated with Uveitis treatment should be initiated early and continue until complete resolution. Corticosteroids have been the mainstay of therapy and can be given topically, as a periocular or intravitreal injection, via an implantable depot preparation, or orally. Risks of cataract and glaucoma can limit the ongoing 作者: 多山 時間: 2025-3-25 21:20
Medical Management of CME Associated with Diabetespathy Study (ETDRS), several trials have evaluated new treatments for DME. Currently, the medical management of DME includes systemic risk factor modification, topical medications, intraocular steroids, and anti-VEGF medications. While the ideal treatment regimen has not been identified, there are s作者: consolidate 時間: 2025-3-26 01:02
Medical Management of CME Associated with Retinal Vascular OcclusionsVO). The introduction of intravitreal therapy has revolutionized the treatment of macular edema secondary to RVO. Intravitreal anti-VEGF therapy with ranibizumab and aflibercept has been approved for the treatment of RVO. Additionally, sustained-release intravitreal dexamethasone implants have gaine作者: Demulcent 時間: 2025-3-26 06:57 作者: 推延 時間: 2025-3-26 11:06 作者: SLAY 時間: 2025-3-26 13:39
Surgical Management of Diabetic Macular Edemaincreasingly implicated in select patients. Surgical interventions, including vitrectomy, epiretinal membrane (ERM) peel, and internal limiting membrane (ILM) peel, have been proposed in these patients to relieve traction, clear cytokines, and improve oxygenation. This chapter reviews the efficacy o作者: 變化無常 時間: 2025-3-26 17:50 作者: 監(jiān)禁 時間: 2025-3-26 23:36
Conclusion and Outlook for the Future in this text – Part 1, Pathophysiology and Diagnosis of CME; Part II, Medical Management of CME; and Part III, Surgical Management of CME. It is clear that understanding the pathophysiology of this disease with its many different causes will result in the future development of therapeutic options t作者: Mendacious 時間: 2025-3-27 01:10 作者: Psa617 時間: 2025-3-27 05:17 作者: 開頭 時間: 2025-3-27 09:59 作者: Cleave 時間: 2025-3-27 14:50 作者: 脆弱吧 時間: 2025-3-27 21:31
978-3-319-81961-7Springer International Publishing Switzerland 2017作者: intention 時間: 2025-3-28 00:24
Mechanisms of Macular Edemarease in retinal thickness, the formation of intraretinal cysts, and the accumulation of subretinal fluid (Fig. 1). Whether distinct pathogenic mechanisms induce different types of fluid accumulation is unclear.作者: neolith 時間: 2025-3-28 05:33
Diagnosis of Cystoid Macular Edema: Imaging and noncontact slit lamp biomicroscopy, indirect ophthalmoscopy, fluorescein angiography (FA), and fundus stereo photography. However the interpretation of their results can be subjective, and subtle changes in retinal thickness in early CME may not be evident.作者: 配偶 時間: 2025-3-28 07:44
Conclusion and Outlook for the Future in this text – Part 1, Pathophysiology and Diagnosis of CME; Part II, Medical Management of CME; and Part III, Surgical Management of CME. It is clear that understanding the pathophysiology of this disease with its many different causes will result in the future development of therapeutic options that do not exist today.作者: 可行 時間: 2025-3-28 11:02 作者: Silent-Ischemia 時間: 2025-3-28 15:01
https://doi.org/10.1007/978-3-476-05665-8Central retinal artery occlusion leads to a sudden blockage of blood supply to inner retina, resulting in severe vision loss. It is an ophthalmic emergency and widely accepted to be the ocular analogue of acute ischemic cerebral stroke. The risk factors are similar to cerebral stroke and ischemic heart disease [1].作者: Ganglion 時間: 2025-3-28 19:42
https://doi.org/10.1007/978-3-476-05665-8Cataract surgery is presently among the most frequently performed surgical procedures worldwide. Although the technique has developed greatly in recent years, with maneuvers becoming safer and less traumatic, some definitive risks still exist.作者: 尋找 時間: 2025-3-29 02:56 作者: 航海太平洋 時間: 2025-3-29 04:54
Surgical Management of Cystoid Macular Edema Associated with Retinal Vascular OcclusionsCentral retinal artery occlusion leads to a sudden blockage of blood supply to inner retina, resulting in severe vision loss. It is an ophthalmic emergency and widely accepted to be the ocular analogue of acute ischemic cerebral stroke. The risk factors are similar to cerebral stroke and ischemic heart disease [1].作者: 夸張 時間: 2025-3-29 10:33 作者: LEERY 時間: 2025-3-29 13:59
Shlomit Schaal,Henry J. KaplanDescribes the medical and surgical management of cystoid macular edema (CME) in relation to its various causes.Explains pathophysiologic mechanisms and structural changes relevant to therapy.Meets the作者: 抗生素 時間: 2025-3-29 19:04 作者: sultry 時間: 2025-3-29 22:27
Prussia (Germany). Ministerial-forstbureau termed “cystoid macular edema” (CME), which represents the collection of excess fluid in “cysts” within the neurosensory retina, it is more broadly defined as extracellular accumulation of fluid within the outer plexiform layer of the retina. Thus, CME should be referred to as a subtype of macular 作者: 售穴 時間: 2025-3-29 23:59
Anleitung zur chemischen Analyse des Weinesrease in retinal thickness, the formation of intraretinal cysts, and the accumulation of subretinal fluid (Fig. 1). Whether distinct pathogenic mechanisms induce different types of fluid accumulation is unclear.作者: 嚴厲譴責 時間: 2025-3-30 07:31
H. Schloesser,Wilhelm Will (Ingenieur) and noncontact slit lamp biomicroscopy, indirect ophthalmoscopy, fluorescein angiography (FA), and fundus stereo photography. However the interpretation of their results can be subjective, and subtle changes in retinal thickness in early CME may not be evident.作者: Flounder 時間: 2025-3-30 11:14
und andere Erz?hlungen (1946) : treatment should be initiated early and continue until complete resolution. Corticosteroids have been the mainstay of therapy and can be given topically, as a periocular or intravitreal injection, via an implantable depot preparation, or orally. Risks of cataract and glaucoma can limit the ongoing 作者: 多產魚 時間: 2025-3-30 12:56
https://doi.org/10.1007/978-3-476-05665-8pathy Study (ETDRS), several trials have evaluated new treatments for DME. Currently, the medical management of DME includes systemic risk factor modification, topical medications, intraocular steroids, and anti-VEGF medications. While the ideal treatment regimen has not been identified, there are s
